Literature DB >> 1834320

Biochemistry and genetics of Tay-Sachs disease.

R A Gravel1, B L Triggs-Raine, D J Mahuran.   

Abstract

Tay-Sachs disease is one of the few neurodegenerative diseases of known causes. It results from mutations of the HEXA gene encoding the alpha subunit of beta-hexosaminidase, producing a destructive ganglioside accumulation in lysosomes, principally in neurons. With the determination of the protein sequence of the alpha and beta subunits, deduced from cDNA sequences, the complex pathway of subcellular and lysosomal processing of the enzyme has been determined. More recently, detailed knowledge of the gene structure has allowed the determination of specific mutations causing Tay-Sachs disease. The high incidence of the disease in Ashkenazi Jews is attributed predominantly to three mutations present in high frequency, while in non-Jews some two dozen mutations have been identified thus far. The cataloguing of mutations has important implications for carrier screening and prenatal diagnosis for Tay-Sachs disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834320     DOI: 10.1017/s0317167100032583

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates.

Authors:  Jagdeep S Walia; Naderah Altaleb; Alexander Bello; Christa Kruck; Matthew C LaFave; Gaurav K Varshney; Shawn M Burgess; Biswajit Chowdhury; David Hurlbut; Richard Hemming; Gary P Kobinger; Barbara Triggs-Raine
Journal:  Mol Ther       Date:  2014-12-17       Impact factor: 11.454

2.  A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.

Authors:  B L Triggs-Raine; E H Mules; M M Kaback; J S Lim-Steele; C E Dowling; B R Akerman; M R Natowicz; E E Grebner; R Navon; J P Welch
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

3.  The molecular basis of HEXA mRNA deficiency caused by the most common Tay-Sachs disease mutation.

Authors:  D J Boles; R L Proia
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

4.  Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.

Authors:  B L Triggs-Raine; B R Akerman; J T Clarke; R A Gravel
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

5.  Hexb enzyme deficiency leads to lysosomal abnormalities in radial glia and microglia in zebrafish brain development.

Authors:  Laura E Kuil; Anna López Martí; Ana Carreras Mascaro; Jeroen C van den Bosch; Paul van den Berg; Herma C van der Linde; Kees Schoonderwoerd; George J G Ruijter; Tjakko J van Ham
Journal:  Glia       Date:  2019-05-29       Impact factor: 7.452

6.  Investigating Immune Responses to the scAAV9-HEXM Gene Therapy Treatment in Tay-Sachs Disease and Sandhoff Disease Mouse Models.

Authors:  Shalini Kot; Subha Karumuthil-Melethil; Evan Woodley; Violeta Zaric; Patrick Thompson; Zhilin Chen; Erik Lykken; John G Keimel; William F Kaemmerer; Steven J Gray; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

7.  Phylogenetic analyses suggest multiple changes of substrate specificity within the glycosyl hydrolase 20 family.

Authors:  Jari Intra; Giulio Pavesi; David S Horner
Journal:  BMC Evol Biol       Date:  2008-07-22       Impact factor: 3.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.